253 results on '"Lundkvist J"'
Search Results
2. Pricing and Reimbursement of Drugs in Sweden
3. Correction to: Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia
4. Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia
5. Powerful Anticonvulsant Action of IL-1 Receptor Antagonist on Intracerebral Injection and Astrocytic Overexpression in Mice
6. Screening for Abdominal Aortic Aneurysm in 65-Year-old Men Remains Cost-effective with Contemporary Epidemiology and Management
7. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
8. The burden of rheumatoid arthritis and access to treatment: health burden and costs
9. Screening for Abdominal Aortic Aneurysm among Patients Referred to the Vascular Laboratory is Cost-effective
10. Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women
11. The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly
12. Analisi dei costi in pazienti ad alto rischio di nefropatia indotta da mezzo di contrasto: i risultati per l’Italia dello studio NEPHRIC
13. PND34 RESOURCE USE RELATED TO CERVICAL DYSTONIA, PEDIATRIC LOWER LIMB SPASTICITY AND ADULT UPPER LIMB SPASTICITY IN THE UNITED KINGDOM: A PHYSICIAN QUESTIONNAIRE
14. PND6 ECONOMIC ANALYSIS OF REAL-WORLD USE OF BOTULINUMTOXINA PRODUCTS (BONTA) FOR TREATMENT OF ADULT UPPER LIMB SPASTICITY (AUL)
15. PND8 NETWORK META-ANALYSIS OF DYSPORT (ABOBOTULINUMTOXINA), BOTOX (ONABOTULINUMTOXINA) AND XEOMIN (INCOBOTULINUMTOXINA) FOR THE TREATMENT OF ADULT LOWER LIMB SPASTICITY (ALLS) IN POST-STROKE POPULATION
16. PND10 INDIRECT TREATMENT COMPARISON OF BOTULINUM TOXINS A FOR THE TREATMENT OF PEDIATRIC UPPER LIMB SPASTICITY
17. PND13 NETWORK META-ANALYSIS FOR BOTULINUM TOXIN A FOR THE TREATMENT OF ADULT LOWER LIMB SPASTICITY (ALLS) IN POST-STROKE POPULATION
18. PMU142 ASSESSING THE HUMAN AND ECONOMIC BURDEN OF SHORT STATURE: A SYSTEMATIC LITERATURE REVIEW
19. PND31 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF POST-STROKE UPPER LIMB SPASTICITY
20. PND30 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF CERVICAL DYSTONIA
21. PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS
22. PND58 - COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH ABOBOTULINUMTOXINA COMPARED TO BEST SUPPORTIVE CARE IN PATIENTS WITH UPPER LIMB SPASTICITY IN SWEDEN
23. Erratum: The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly
24. Time and value of chemotherapy administration burden in a Swedish hospital
25. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea
26. The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study
27. Abstract P6-11-06: Time and value of chemotherapy administration burden in a Swedish hospital
28. The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) Profile without affecting Notch processing
29. Pricing and reimbursement of drugs in Sweden
30. Screening for Abdominal Aortic Aneurysm in 65-Year-old Men Remains Cost-effective with Contemporary Epidemiology and Management
31. Health care costs for treatment of disseminated breast cancer
32. Biological activity and brain actions of recombinant rat interleukin-1 alpha and interleukin-1 beta
33. Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis
34. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy
35. Alzheimer's Disease: Presenilin 2-Sparing -Secretase Inhibition Is a Tolerable A Peptide-Lowering Strategy
36. PMS36 Cost-Effectiveness of Denosumab for the Treatment of Elderly Women With Post-Menopausal Osteoporosis in Sweden
37. Pen-2 Is Sequestered in the Endoplasmic Reticulum and Subjected toUbiquitylation and Proteasome-mediated Degradation in the Absence ofPresenilin.
38. Cost-effectiveness of iodixamol (IOCM) compared with iohexol (LOCM) in patietns at risk of contrast- induced nephropathy undergoing angiography in Sweden : Economic analysis based on the NEPHRIC study
39. APP intracellular domain formation and unaltered signaling in the presenceof familial Alzheimer's disease mutations.
40. AD2 THE SOCIETAL BURDEN OF POOR PERSISTENCE TO TREATMENT OF OSTEOPOROSIS IN SWEDEN
41. A cost-effective method for monitoring airborne particulate matter using tabletop SEM-EDS
42. The more time spent on listening - the less time spent on prescribing antibiotics in general practice.
43. The more time spent on listening, the less time spent on prescribing antibiotics in general practice
44. Improved Long-Term Survival After Abdominal Aortic Aneurysm Repair
45. Health care costs for treatment of disseminated breast cancer
46. PCN38 COST-EFFECTIVENESS OF EXTENDED ADJUVANT TREATMENT WITH LETROZOLE IN SWEDEN
47. Nab-paclitaxel or docetaxel as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): a cost utility analysis in five European countries
48. PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC): A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES
49. Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK)
50. The burden of rheumatoid arthritis and access to treatment: health burden and costs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.